No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Technology firm GenIP has expanded into the Republic of Chile through an engagement for 30 analytical assessment orders from a leading research institution.
GenIP said on Tuesday that the order has increased the total value of Invention Evaluator orders received since its IPO in October 2024 to more than $850,000.
Chief executive Melissa Cruz said: "I am delighted to announce another new international contract with a leading research university, marking GenIP's first entry into the Chilean market. The institution has purchased 30 Invention Evaluator assessments, to support technology commercialisation decisions across its research portfolio.
"GenIP's global expansion is underpinned by a healthy balance sheet that allows the company to capitalise on opportunities as they arise."
As of 0835 BST, GenIP shares were 7.11% higher at 28.92p.
Reporting by Iain Gilbert at Sharecast.com
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.